323 related articles for article (PubMed ID: 17213254)
21. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.
Barton GR; Sach TH; Avery AJ; Jenkinson C; Doherty M; Whynes DK; Muir KR
Health Econ; 2008 Jul; 17(7):815-32. PubMed ID: 17893863
[TBL] [Abstract][Full Text] [Related]
23. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain.
Obradovic M; Lal A; Liedgens H
Health Qual Life Outcomes; 2013 Jul; 11():110. PubMed ID: 23815777
[TBL] [Abstract][Full Text] [Related]
24. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
25. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
27. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
28. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
Bharmal M; Thomas J
Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
[TBL] [Abstract][Full Text] [Related]
29. The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures.
Slobogean GP; Noonan VK; O'Brien PJ
J Shoulder Elbow Surg; 2010 Apr; 19(3):342-8. PubMed ID: 20189839
[TBL] [Abstract][Full Text] [Related]
30. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF; Buskens E
Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
[TBL] [Abstract][Full Text] [Related]
32. Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.
Bjerk M; Brovold T; Davis JC; Bergland A
Qual Life Res; 2019 Dec; 28(12):3187-3195. PubMed ID: 31364036
[TBL] [Abstract][Full Text] [Related]
33. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
[TBL] [Abstract][Full Text] [Related]
34. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
35. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.
Haywood KL; Garratt AM; Dziedzic K; Dawes PT
Rheumatology (Oxford); 2002 Dec; 41(12):1380-7. PubMed ID: 12468817
[TBL] [Abstract][Full Text] [Related]
36. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.
Leung YY; Png ME; Wee HL; Thumboo J
J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
Walters SJ; Brazier JE
Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932
[TBL] [Abstract][Full Text] [Related]
38. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T
Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
[TBL] [Abstract][Full Text] [Related]
39. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
Dritsaki M; Petrou S; Williams M; Lamb SE
Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833
[TBL] [Abstract][Full Text] [Related]
40. [Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D].
Du XD; Zhu P; Li ME; Wang J; Meng HD; Zhu CR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):252-257. PubMed ID: 29737071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
